Drinking more fluid roughly halves kidney-stone recurrence, trials show

Low fluid intake is a real and well-evidenced risk factor for kidney stones, and the flip side is the most strongly supported prevention there is: drinking enough to keep urine plentiful roughly halves the chance of forming another stone [s1]. It outranks any specific dietary tweak, and it is the first thing clinical guidelines recommend [s2].

Does low fluid intake cause stones?

The cleanest evidence is preventive rather than causal — trials raise fluid intake and count fewer stones — but the two questions are mirror images. If increasing fluid roughly halves recurrence, then habitually low fluid intake is, correspondingly, a modifiable risk factor for forming stones in the first place [s1]. What the trials establish directly is the intervention side of that equation, which is also the side a person can act on.

What the trials found

The evidence base was assembled in a systematic review for the American College of Physicians, published in Annals of Internal Medicine, which pooled 28 randomised controlled trials of treatments to prevent recurrent stones [s1]. The clearest result was for fluid. In people who had already had one calcium stone, increasing fluid intake halved the risk of a recurrent stone compared with no treatment — a relative risk of 0.45 (95% confidence interval 0.24 to 0.84) [s1]. The same review found that cutting soft-drink consumption modestly reduced recurrent symptomatic stones (RR 0.83, 95% CI 0.71 to 0.98) [s1].

For people who had already had multiple stones — most of whom were already drinking more fluid — specific medicines added further protection: thiazide diuretics (RR 0.52), citrate (RR 0.25), and allopurinol (RR 0.59), though the benefit of allopurinol appeared limited to people with high uric acid levels in blood or urine [s1]. The hierarchy is worth noting: fluid first, medicines layered on top when stones keep coming.

Two further findings from the same review shape how this is used. First, baseline blood and urine chemistry did not reliably predict who would benefit from which treatment, which undercuts the intuition that a stone-former can be neatly sorted by lab tests into a tailored regimen [s1]. Second, the tolerability gap was real: there were few withdrawals among people assigned to increased fluid intake, but more among those on the drug treatments [s1]. That matters because a prevention that people actually keep up beats a more potent one they abandon — and fluid, uniquely, is both the best-tolerated and the first-line option.

How much, and of what

The companion ACP clinical practice guideline turns this into a concrete, if deliberately hedged, target. Its first recommendation is increased fluid intake spread throughout the day to achieve at least 2 litres of urine per day — the recommendation is graded weak, on low-quality evidence, which is the guideline's own honest signal about the strength of the underlying trials [s2]. The target is framed as urine output rather than cups consumed, because how much someone needs to drink to reach 2 litres of urine varies with climate, activity and how much they sweat.

The guideline's second recommendation reserves drugs — a thiazide, citrate, or allopurinol — for people whose stones recur despite increased fluid, rather than as a first step [s2]. That ordering matters: the pharmacologic options carry side effects and dropouts, whereas the fluid intervention had few withdrawals in the trials [s1].

The limits

The evidence, by the guideline's own grading, is not airtight — most trials studied people with idiopathic calcium stones, and nearly all counted a composite outcome that included stones found on imaging without symptoms, not only painful ones [s1]. The reviews also do not establish an exact daily volume of water that suits everyone, which is why the target is expressed as urine output and why the recommendation is graded weak [s2]. Stone chemistry varies too; the fluid finding is most directly established for calcium stones [s1].

What this leaves a reader with

The popular belief that staying well-hydrated helps prevent kidney stones is, unusually, one the trial evidence backs — increased fluid roughly halved recurrence in people who had already had a stone [s1] [s2]. What the evidence does not do is set a universal number of glasses; the goal is enough fluid to keep urine dilute and plentiful, which is a reasonable thing to work out with a clinician, especially for anyone who has had stones or has other conditions affecting fluid balance.

This article is informational and is not medical advice.

Sources

• Medical Management to Prevent Recurrent Nephrolithiasis in Adults: A Systematic Review for an American College of Physicians Clinical Guideline — Annals of Internal Medicine, 2013-04-02
• Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians — Annals of Internal Medicine, 2014-11-01